Role of the surgeon as a variable in the treatment of rectal cancer

被引:52
作者
Hermanek, P [1 ]
Hermanek, PJ [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Surg, Erlangen, Germany
来源
SEMINARS IN SURGICAL ONCOLOGY | 2000年 / 19卷 / 04期
关键词
rectal neoplasms; colorectal surgery; clinical trials; quality assurance; health care;
D O I
10.1002/ssu.3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasingly, data are being accumulated on the influence of intersurgeon variability on outcome after curative surgical treatment of rectal carcinoma. Thus, today the individual surgeon has to be considered as an independent factor influencing locoregional recurrence, as well as survival rates. In general, higher local control and survival can be expected for specialized colorectal surgeons. There are no clear correlations between surgical volume and outcome. Interinstitutional variability in treatment results reflects intersurgeon variability, but analysis is generally more difficult because of a lack of homogeneity with respect to different confounding factors. There are several factors in surgical technique that are important for long-term outcome. Of greatest apparent importance is the adequacy of mesorectal excision (for carcinomas of the middle and lower third, total mesorectal excision; for carcinomas of the upper third, mesorectal, excision down to a mesorectal plane 5 cm distal to the gross tumor margin detected by the surgeon in situ). Furthermore, intraoperative local tumor spillage (tumor perforation during mobilization, incision into the tumor), en bloc resection technique, skill, and the extent of regional lymphadenectomy may influence outcome. For quality assurance, detailed operative reports are required, as well as histopathology examinations concerning indicators of surgical oncologic quality discernable from the resection specimens. In future clinical trials of multimodal treatment of rectal cancer, quality assurance of surgery and pathology is necessary for consideration of the surgeon and surgical technique prognostic factors. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 39 条
  • [1] Survival after rectal cancer:: differences between hospital catchment areas.: A nationwide study in Sweden
    Blomqvist, P
    Ekbom, A
    Nyrén, O
    Krusemo, UB
    Bergström, R
    Adami, HO
    [J]. GUT, 1999, 45 (01) : 39 - 44
  • [2] Factors affecting survival after excision of the rectum for cancer - A multivariate analysis
    Bokey, EL
    Chapuis, PH
    Dent, OF
    Newland, RC
    Koorey, SG
    Zelas, PJ
    Stewart, PJ
    [J]. DISEASES OF THE COLON & RECTUM, 1997, 40 (01) : 3 - 10
  • [3] ENKER WE, 1995, J AM COLL SURGEONS, V181, P335
  • [4] Giacomantonio C A, 2000, Surg Oncol Clin N Am, V9, P51
  • [5] Goldberg S, 1998, SEMIN SURG ONCOL, V15, P87, DOI 10.1002/(SICI)1098-2388(199809)15:2<87::AID-SSU5>3.0.CO
  • [6] 2-1
  • [7] Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients
    Havenga, K
    Enker, WE
    Norstein, J
    Moriya, Y
    Heald, RJ
    van Houwelingen, HC
    van de Velde, CJH
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (04): : 368 - 374
  • [8] Rectal cancer - The Basingstoke experience of total mesorectal excision, 1978-1997
    Heald, RJ
    Moran, BJ
    Ryall, RDH
    Sexton, R
    MacFarlane, JK
    [J]. ARCHIVES OF SURGERY, 1998, 133 (08) : 894 - 898
  • [9] THE MESORECTUM IN RECTAL-CANCER SURGERY - THE CLUE TO PELVIC RECURRENCE
    HEALD, RJ
    HUSBAND, EM
    RYALL, RDH
    [J]. BRITISH JOURNAL OF SURGERY, 1982, 69 (10) : 613 - 616
  • [10] HERMANEK P, 1995, TUMORI, V81, P60